Susquehanna International Group, LLP Ligand Pharmaceuticals Inc Put Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Put Options

27 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	SELL	$68.53 - $87.91 $507,122 - $650,534	-7,400 Reduced 52.86%	6,600 $556,000
Q1 2024 May 07, 2024	BUY	$68.64 - $89.2 $116,688 - $151,640	1,700 Added 13.82%	14,000 $1.02 Million
Q4 2023 Feb 14, 2024	SELL	$49.57 - $72.63 $104,097 - $152,523	-2,100 Reduced 14.58%	12,300 $878,000
Q3 2023 Nov 14, 2023	SELL	$58.86 - $72.67 $523,854 - $646,763	-8,900 Reduced 38.2%	14,400 $862,000
Q2 2023 Aug 11, 2023	BUY	$69.53 - $79.33 $1.25 Million - $1.43 Million	18,000 Added 339.62%	23,300 $1.68 Million
Q1 2023 May 16, 2023	BUY	$65.67 - $77.08 $348,051 - $408,524	5,300 New	5,300 $389,000
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $2 - $21,512	200 Added 4.65%	4,500 $387,000
Q2 2022 Aug 15, 2022	SELL	$74.52 - $117.06 $1.25 Million - $1.97 Million	-16,800 Reduced 79.62%	4,300 $384,000
Q1 2022 May 16, 2022	BUY	$94.99 - $151.56 $360,962 - $575,928	3,800 Added 21.97%	21,100 $2.37 Million
Q4 2021 Feb 14, 2022	SELL	$127.69 - $165.85 $1.97 Million - $2.55 Million	-15,400 Reduced 47.09%	17,300 $2.67 Million
Q3 2021 Nov 15, 2021	SELL	$102.33 - $144.73 $5.26 Million - $7.44 Million	-51,400 Reduced 61.12%	32,700 $4.56 Million
Q2 2021 Aug 11, 2021	SELL	$113.03 - $155.64 $2.63 Million - $3.63 Million	-23,300 Reduced 21.69%	84,100 $11 Million
Q1 2021 May 17, 2021	SELL	$99.52 - $215.83 $3.45 Million - $7.49 Million	-34,700 Reduced 24.42%	107,400 $16.4 Million
Q4 2020 Feb 16, 2021	BUY	$80.55 - $106.05 $6.12 Million - $8.06 Million	76,000 Added 114.98%	142,100 $14.1 Million
Q3 2020 Nov 16, 2020	SELL	$89.56 - $126.72 $8.34 Million - $11.8 Million	-93,100 Reduced 58.48%	66,100 $6.3 Million
Q2 2020 Aug 14, 2020	BUY	$68.28 - $123.65 $6.06 Million - $11 Million	88,700 Added 125.82%	159,200 $17.8 Million
Q1 2020 May 15, 2020	BUY	$63.37 - $107.88 $823,810 - $1.4 Million	13,000 Added 22.61%	70,500 $5.13 Million
Q4 2019 Feb 14, 2020	SELL	$96.94 - $113.59 $29.6 Million - $34.7 Million	-305,600 Reduced 84.16%	57,500 $6 Million
Q3 2019 Nov 14, 2019	SELL	$86.25 - $120.16 $1.98 Million - $2.76 Million	-23,000 Reduced 5.96%	363,100 $36.1 Million
Q2 2019 Aug 14, 2019	SELL	$107.38 - $129.34 $3.45 Million - $4.15 Million	-32,100 Reduced 7.68%	386,100 $44.1 Million
Q1 2019 May 15, 2019	BUY	$105.93 - $142.47 $36.2 Million - $48.7 Million	341,500 Added 445.24%	418,200 $52.6 Million
Q4 2018 Feb 14, 2019	BUY	$128.36 - $272.13 $5.13 Million - $10.9 Million	40,000 Added 108.99%	76,700 $10.4 Million
Q3 2018 Nov 14, 2018	SELL	$211.18 - $274.49 $1.01 Million - $1.32 Million	-4,800 Reduced 11.57%	36,700 $10.1 Million
Q2 2018 Aug 14, 2018	BUY	$150.77 - $207.98 $30,154 - $41,596	200 Added 0.48%	41,500 $8.6 Million
Q1 2018 May 15, 2018	BUY	$138.63 - $182.62 $4.35 Million - $5.73 Million	31,400 Added 317.17%	41,300 $6.82 Million
Q4 2017 Feb 14, 2018	BUY	$128.36 - $147.04 $25,672 - $29,408	200 Added 2.06%	9,900 $1.36 Million
Q3 2017 Nov 14, 2017	BUY	$120.91 - $137.94 $1.17 Million - $1.34 Million	9,700	9,700 $1.32 Million

Others Institutions Holding LGND

# of Institutions

256

Shares Held

18.1M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.94B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account